User:Mr. Ibrahem/Balsalazide

Balsalazide, sold under the brand name Colazide among others, is a medication used to treat ulcerative colitis (UC) and Crohn's disease. In UC it is used for mild to moderate disease and usually only for up to 12 weeks. It is take by mouth.

Common side effects include headache, feeling sick, stomach upset, diarrhea, joint pain, and respiratory infections. Other side effects may include blood disorder, gallstones, or a lupus-like syndrome. Safety in pregnancy is unclear. An alternative may be required for people with asthma, kidney or liver problems. Balsalazide passes unchanged through the stomach and small bowel, and releases mesalazine (5-ASA) when it reaches the large bowel, where ulcerative colitis affects.

Balsalazide was first made in the 1980s and approved for medical use in the United Kingdom in 1997. It is available as a generic medication. In the United Kingdom a months supply at the maintenance dose costs the NHS around £30 as of 2021. In the United States this amount costs about US$74.